Vistin Pharma ASA Asset Resilience Ratio

Latest as of March 2025: 3.08%

Vistin Pharma ASA asset resilience ratio. Vistin Pharma ASA (VISTN) has an Asset Resilience Ratio of 3.08% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Vistin Pharma ASA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Nkr12.67 Million

≈ $1.33 Million USD Cash + Short-term Investments

Total Assets

Nkr411.55 Million

≈ $43.31 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Vistin Pharma ASA (2016–2023)

Asset resilience ratio of Vistin Pharma ASA from 2016 to 2023. This chart shows how Vistin Pharma ASA's Asset Resilience Ratio has changed over time. Read Vistin Pharma ASA (VISTN) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Vistin Pharma ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see VISTN asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr12.67 Million	3.08%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr12.67 Million	3.08%

Asset Resilience Insights

Limited Liquidity: Vistin Pharma ASA maintains only 3.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Vistin Pharma ASA Industry Peers by Asset Resilience Ratio

Compare Vistin Pharma ASA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Vistin Pharma ASA Asset Resilience Ratio by Year (2016–2023)

Vistin Pharma ASA asset resilience ratio by year from 2016 to 2023. The table below shows the annual Asset Resilience Ratio data for Vistin Pharma ASA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	6.50%	Nkr26.20 Million ≈ $2.76 Million	Nkr403.40 Million ≈ $42.45 Million	+6.14pp
2022-12-31	0.35%	Nkr1.44 Million ≈ $151.00K	Nkr407.21 Million ≈ $42.85 Million	-23.58pp
2020-12-31	23.93%	Nkr77.04 Million ≈ $8.11 Million	Nkr321.92 Million ≈ $33.87 Million	-12.75pp
2019-12-31	36.68%	Nkr184.91 Million ≈ $19.46 Million	Nkr504.17 Million ≈ $53.05 Million	-10.03pp
2018-12-31	46.71%	Nkr233.58 Million ≈ $24.58 Million	Nkr500.06 Million ≈ $52.62 Million	+14.71pp
2016-12-31	32.00%	Nkr89.44 Million ≈ $9.41 Million	Nkr279.52 Million ≈ $29.41 Million	--

pp = percentage points

About Vistin Pharma ASA

OL:VISTN Norway Drug Manufacturers - Specialty & Generic

Market Cap

$85.86 Million

Nkr815.94 Million NOK

Market Cap Rank

#19584 Global

#175 in Norway

Share Price

Nkr18.40

Change (1 day)

-1.08%

52-Week Range

Nkr18.00 - Nkr23.20

All Time High

Nkr28.06